dc.creatorTeixeira, M
dc.date2009
dc.dateDEC
dc.date2014-08-01T18:24:15Z
dc.date2015-11-26T17:57:57Z
dc.date2014-08-01T18:24:15Z
dc.date2015-11-26T17:57:57Z
dc.date.accessioned2018-03-29T00:41:32Z
dc.date.available2018-03-29T00:41:32Z
dc.identifierRevista Latinoamericana De Psicopatologia Fundamental. Assoc Univ Pequisa Psicopatologia Fundamental, v. 12, n. 4, n. 731, n. 742, 2009.
dc.identifier1415-4714
dc.identifierWOS:000273213300008
dc.identifierhttp://www.repositorio.unicamp.br/jspui/handle/REPOSIP/78424
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/78424
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1291623
dc.descriptionThis article discusses one more way that the industry of pharmaceutics and medical devices affects medicine, namely, by financing on-going medical educational activities with the objective of promoting the use of treatments that are profitable to these companies. On-going medical education is required in many states of the U.S.A. as a condition,for physicians to renew their licenses to practice medicine. The U.S. Congress is discussing how to regulate the matter in the context of the national health system reform now under discussion in that country.
dc.description12
dc.description4
dc.description731
dc.description742
dc.languagept
dc.publisherAssoc Univ Pequisa Psicopatologia Fundamental
dc.publisherSao Paolo Sp
dc.publisherBrasil
dc.relationRevista Latinoamericana De Psicopatologia Fundamental
dc.relationRev. Latinoam. Psicopatol. Funda.
dc.rightsaberto
dc.sourceWeb of Science
dc.subjectPharmaceutical industry
dc.subjectmedical education
dc.subjectdoctor-patient relationship
dc.titleThe billion-dollar industry of on-going medical education in the USA: one more ways the medical-product industry intervenes in doctor-patient relationships
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución